Cardiology
Among patients with recent ACS, use of enzyme inhibitor does not reduce risk of cardiovascular event
Stephen J. Nicholls, M.B.B.S., Ph.D., of the South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, Australia, and colleagues determined the effects of varespladib, a drug that inhibits ...
Nov 18, 2013
0
1